SCHEMBL24834926

SCHEMBL24834926

Cc1cc(C(=O)OC(C)(C)C)c(C)n1CC1=CC=CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 4/20 0.41
▸ GAA P10253 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ TDP1 Q9NUW8 2/20 0.38
▸ NOTUM Q6P988 2/20 0.37
▸ MAPT P10636 2/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.33
▸ S1PR2 O95136 1/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ POLB P06746 2/20 0.32
▸ KLKB1 P03952 2/20 0.32
▸ KLK1 P06870 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ RECQL P46063 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24834367 0.72 RAB9A (0.59) TSHRLMNASMN1; SMN2TDP1MAPT
SCHEMBL19048267 0.68 NOTUM (0.46) TSHRGAALMNASMN1; SMN2TDP1
SCHEMBL13947267 0.66 CA12 (0.33) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL16005033 0.64 CA12 (0.40) KMT2A
SCHEMBL828580 0.62 EGFR (0.41) TSHRTDP1MAPTALDH1A1HSD17B10
SCHEMBL14886580 0.61 NOTUM (0.47) TSHRLMNASMN1; SMN2NOTUMMAPT
SCHEMBL6350428 0.61 CYP2C9 (0.41) MEN1KMT2ANPSR1
SCHEMBL15568745 0.61 KMT2A (0.34) GAALMNAMAPTMEN1KMT2A
SCHEMBL1407974 0.60 TP53 (0.34) MAPTMEN1KMT2AALDH1A1HSD17B10
SCHEMBL15567724 0.60 GPR35 (0.39) GAASMN1; SMN2TDP1NOTUMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023274251-A1 POLYCYCLIC COMPOUND FOR INHIBITING RNA HELICASE DHX33, AND APPLICATION OF COMPOUND 深圳开悦生命科技有限公司 2023-01-05 — — WO disclosed
Send feedback